Tobacco.org

• Imperial Tobacco Canada expands harm reduction program with start of SNUS test market in Ottawa 

As part of its harm reduction program, Imperial Tobacco Canada announces today that Ottawa will be the site of the Company's next test market for its Swedish-style snus smokeless tobacco product.

"The health risks associated with smoking tobacco products are well understood, the prices are high and restrictions are strict, yet about five million adults in Canada smoke. Imperial Tobacco Canada believes that it is the right thing to provide people products that are potentially less harmful than smoking," said Benjamin Kemball, president and CEO of Imperial Tobacco Canada.

Jump to full article »

Harm reduction, particularly when it comes to tobacco products, is an important public health issue. If harm reduction products are to be pursued and be effective, we need to look at how best to regulate this new category in a way that makes people aware of their choices and accurately reflects the risk reduction potential and the remaining health risks. To do so we need the input of all stakeholders such as the government and the scientific community.
Benjamin Kemball, president and CEO of Imperial Tobacco Canada, which has announced that Ottawa will be the site of the Company's next test market for its snus product.

The health risks associated with smoking tobacco products are wellunderstood, the prices are high and restrictions are strict, yet about five million adults in Canada smoke. Imperial Tobacco Canada believes that it is the right thing to provide people products that are potentially less harmful than smoking.
Benjamin Kemball, president and CEO of Imperial Tobacco Canada, which has announced that Ottawa will be the site of the Company's next test market for its snus product.